7 research outputs found
Statut du gĂšne Cdx2 dans les cancers colo-rectaux chez l'homme
STRASBOURG-Medecine (674822101) / SudocSudocFranceF
Early double-guidewire versus repeated single-guidewire technique to facilitate selective bile duct cannulation: a randomized controlled trial
International audienceAbstract BackgroundâDuring endoscopic retrograde cholangiopancreatography (ERCP), access to the common bile duct (CBD) can be problematic after unintentional insertion of the guidewire into the pancreatic duct. We conducted a prospective, randomized study in order to compare biliary cannulation success rates of early double-guidewire (EDG) and repeated single-guidewire (RSG) techniques in patients with inadvertent passage of the guidewire into the pancreatic duct. MethodsâPatients with a native papilla were randomly assigned to either the EDG or RSG groups after unintentional insertion of the guidewire into the pancreatic duct. The primary outcome was successful selective CBD cannulation within 10 minutes. The secondary outcomes were successful final selective bile duct cannulation, time to bile duct cannulation, and frequency of post-ERCP pancreatitis (PEP). Resultsâ142 patients were randomized and selective bile duct cannulation was achieved in 57/68 patients (84â%) in the EDG group and in 37/74 patients (50â%) in the RSG group within 10 minutes (relative risk 1.34; 95â% confidence interval 1.08â6.18; Pâ<â0.001). The overall final selective bile duct cannulation rate was 99.3â%. The time to access the CBD was shorter using the EDG technique (6.0 vs. 10.4 minutes; Pâ=â0.002). Mild PEP was not observed more frequently in the EDG group than in the RSG group. ConclusionâThe EDG technique significantly increased the success rate of biliary duct cannulation within 10 minutes compared with an RSG approach
The PRSS3P2 and TRY7 deletion copy number variant modifies risk for chronic pancreatitis
Background
PRSS1 and PRSS2 constitute the only functional copies of a tandemly-arranged five-trypsinogen-gene cluster (i.e., PRSS1, PRSS3P1, PRSS3P2, TRY7 and PRSS2) on chromosome 7q35. Variants in PRSS1 and PRSS2, including missense and copy number variants (CNVs), have been reported to predispose to or protect against chronic pancreatitis (CP). We wondered whether a common trypsinogen pseudogene deletion CNV (that removes two of the three trypsinogen pseudogenes, PRSS3P2 and TRY7) might be associated with CP causation/predisposition.
Methods
We analyzed the common PRSS3P2 and TRY7 deletion CNV in a total of 1536 CP patients and 3506 controls from France, Germany, India and Japan by means of quantitative fluorescent multiplex polymerase chain reaction.
Results
We demonstrated that the deletion CNV variant was associated with a protective effect against CP in the French, German and Japanese cohorts whilst a trend toward the same association was noted in the Indian cohort. Meta-analysis under a dominant model yielded a pooled odds ratio (OR) of 0.68 (95% confidence interval (CI) 0.52â0.89; pâŻ=âŻ0.005) whereas an allele-based meta-analysis yielded a pooled OR of 0.84 (95% CI 0.77â0.92; pâŻ=âŻ0.0001). This protective effect is explicable by reference to the recent finding that the still functional PRSS3P2/TRY7 pseudogene enhancers upregulate pancreatic PRSS2 expression.
Conclusions
The common PRSS3P2 and TRY7 deletion CNV was associated with a reduced risk for CP. This finding provides additional support for the emerging view that dysregulated PRSS2 expression represents a discrete mechanism underlying CP predisposition or protection